Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content

Abstract

Objective:

Substance use initiation during early adolescence is associated with later development of substance use and mental health disorders. This study used various domains to predict substance use initiation, defined as trying any nonprescribed substance (e.g., alcohol, tobacco, cannabis), by age 12, using a large longitudinal data set.

Methods:

Substance-naive youths from the Adolescent Brain Cognitive Development Study (ages 9–10; N=6,829) were followed for 3 years. A total of 420 variables were examined as predictors of substance use initiation, using a penalized logistic regression with elastic net; domains spanned demographic characteristics, self and peer involvement with substance use, parenting behaviors, mental and physical health, culture and environment, hormones, neurocognitive functioning, and structural neuroimaging.

Results:

By age 12, 982 (14.4%) children reported substance initiation, with alcohol being the most common. Models with only self-report predictors had similar prediction performance to models adding hormones, neurocognitive factors, and neuroimaging predictors (AUCtest=0.66). Sociodemographic factors were the most robust predictors, followed by cultural and environmental factors, physical health factors, and parenting behaviors. The top predictor was a religious preference of Mormon (coefficient=−0.87), followed by a religious preference for Jewish (coefficient=0.32), and by Black youths (coefficient=−0.32).

Conclusions:

Sociodemographic variables were the most robust predictors of substance use initiation. Adding resource-intensive measures, including hormones, neurocognitive assessment, and structural neuroimaging, did not improve prediction of substance use initiation. The application of these large-scale findings in clinical settings could help to streamline and tailor prevention and early intervention efforts.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 423 - 433

History

Received: 1 November 2023
Revision received: 13 February 2024
Accepted: 15 February 2024
Published in print: May 01, 2024
Published online: 6 May 2024

Keywords

  1. Child/Adolescent Psychiatry
  2. Development
  3. Substance-Related and Addictive Disorders

Authors

Details

ReJoyce Green, Ph.D. [email protected]
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Bethany J. Wolf, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Andrew Chen, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Anna E. Kirkland, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Pamela L. Ferguson, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Brittney D. Browning, B.S.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Brittany E. Bryant, D.S.W.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Rachel L. Tomko, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Kevin M. Gray, M.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Louise Mewton, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).
Lindsay M. Squeglia, Ph.D.
Department of Psychiatry and Behavioral Sciences (Green, Kirkland, Browning, Bryant, Tomko, Gray, Squeglia) and Department of Public Health Sciences (Wolf, Chen, Ferguson), Medical University of South Carolina, Charleston; Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Mewton).

Notes

Send correspondence to Dr. Green ([email protected]).
Presented in part at the annual meeting of the Research Society on Alcohol, Orlando, Florida, June 25–29, 2022; the annual meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, October 17–22, 2022; and the annual meeting of the Association for Clinical and Translational Science, Washington, DC, April 18–22, 2023.

Competing Interests

Dr. Gray has served as a consultant for Indivior and Jazz Pharmaceuticals and has received research support from Aelis Farma. The other authors report no financial relationships with commercial interests.

Funding Information

Dr. Green was supported in part by a training grant from NIAAA (T32 AA007474) and a career development award from NIDA (K12DA031794). Dr. Wolf is supported in part by the South Carolina Clinical and Translational Research Institute, Medical University of South Carolina’s CTSA, NIH/NCATS (UL1TR001450). Dr. Squeglia is supported in part by NIAAA grant K24AA031052. Drs. Mewton and Squeglia are supported in part by NIAAA grant R01AA030575.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share